Sysmex Corporation (SSMXY)
USD 18.76
(-0.27%)
USD 18.76
(-0.27%)
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2024 | 112.87 Billion JPY | 10.57% |
| 2023 | 102.08 Billion JPY | 7.69% |
| 2022 | 96.99 Billion JPY | 30.06% |
| 2021 | 74.58 Billion JPY | -4.94% |
| 2020 | 78.45 Billion JPY | 2.37% |
| 2019 | 76.64 Billion JPY | 2.75% |
| 2018 | 74.59 Billion JPY | 18.02% |
| 2017 | 63.2 Billion JPY | -13.21% |
| 2016 | 72.82 Billion JPY | 26.94% |
| 2015 | 57.36 Billion JPY | 29.59% |
| 2014 | 44.26 Billion JPY | 44.59% |
| 2013 | 30.61 Billion JPY | 0.0% |
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2024 Q1 | 21.49 Billion JPY | -27.51% |
| 2024 Q2 | 28.99 Billion JPY | 34.85% |
| 2024 Q3 | 28.38 Billion JPY | -4.87% |
| 2024 FY | - JPY | 8.35% |
| 2024 Q4 | 34.31 Billion JPY | 23.13% |
| 2023 Q2 | 28.14 Billion JPY | 53.53% |
| 2023 FY | - JPY | 7.69% |
| 2023 Q4 | 29.65 Billion JPY | 4.65% |
| 2023 Q3 | 28.33 Billion JPY | 0.7% |
| 2023 Q1 | 18.32 Billion JPY | -23.61% |
| 2022 Q3 | 25.05 Billion JPY | -4.49% |
| 2022 Q2 | 26.23 Billion JPY | 20.85% |
| 2022 FY | - JPY | 30.06% |
| 2022 Q1 | 21.71 Billion JPY | -3.58% |
| 2022 Q4 | 23.99 Billion JPY | -4.25% |
| 2021 Q2 | 19.38 Billion JPY | 47.35% |
| 2021 FY | - JPY | -4.94% |
| 2021 Q3 | 22.24 Billion JPY | 14.74% |
| 2021 Q1 | 13.15 Billion JPY | -36.19% |
| 2021 Q4 | 22.51 Billion JPY | 1.23% |
| 2020 Q4 | 20.61 Billion JPY | 8.98% |
| 2020 FY | - JPY | 2.37% |
| 2020 Q3 | 18.91 Billion JPY | -15.07% |
| 2020 Q2 | 22.27 Billion JPY | 30.7% |
| 2020 Q1 | 17.04 Billion JPY | -26.1% |
| 2019 Q3 | 18.09 Billion JPY | -2.15% |
| 2019 FY | - JPY | 2.75% |
| 2019 Q1 | 17.63 Billion JPY | -8.05% |
| 2019 Q2 | 18.48 Billion JPY | 4.84% |
| 2019 Q4 | 23.06 Billion JPY | 27.46% |
| 2018 Q3 | 20.32 Billion JPY | 5.67% |
| 2018 FY | - JPY | 18.02% |
| 2018 Q1 | 15.91 Billion JPY | 3.99% |
| 2018 Q4 | 19.17 Billion JPY | -5.65% |
| 2018 Q2 | 19.23 Billion JPY | 20.87% |
| 2017 Q2 | 15.63 Billion JPY | -8.85% |
| 2017 Q3 | 15.4 Billion JPY | -1.44% |
| 2017 Q4 | 15.3 Billion JPY | -0.66% |
| 2017 FY | - JPY | -13.21% |
| 2017 Q1 | 17.15 Billion JPY | -13.41% |
| 2016 FY | - JPY | 26.94% |
| 2016 Q3 | 18.67 Billion JPY | 1.37% |
| 2016 Q2 | 18.42 Billion JPY | 29.32% |
| 2016 Q1 | 14.24 Billion JPY | -18.56% |
| 2016 Q4 | 19.8 Billion JPY | 6.07% |
| 2015 Q1 | 11.47 Billion JPY | -23.34% |
| 2015 Q4 | 17.49 Billion JPY | 20.64% |
| 2015 Q3 | 14.49 Billion JPY | 4.29% |
| 2015 Q2 | 13.9 Billion JPY | 21.19% |
| 2015 FY | - JPY | 29.59% |
| 2014 Q2 | 11.31 Billion JPY | 59.07% |
| 2014 FY | - JPY | 44.59% |
| 2014 Q4 | 14.96 Billion JPY | 37.66% |
| 2014 Q3 | 10.87 Billion JPY | -3.96% |
| 2014 Q1 | 7.11 Billion JPY | -26.25% |
| 2013 Q3 | 6.59 Billion JPY | -21.49% |
| 2013 Q2 | 8.4 Billion JPY | 0.0% |
| 2013 FY | - JPY | 0.0% |
| 2013 Q4 | 9.64 Billion JPY | 46.29% |
| Name | EBITDA | EBITDA Difference |
|---|---|---|
| American Medical Technologies Inc. | -963.95 Thousand USD | 11709579.913% |
| Ansell Limited | 209.86 Million USD | -53685.045% |
| Ansell Limited | 206.3 Million USD | -54613.524% |
| BG Medicine, Inc. | - USD | -Infinity% |
| Biotage AB (publ) | 42.83 Million USD | -263379.276% |
| BioLife Sciences Inc. | - USD | -Infinity% |
| CB Scientific, Inc. | -1.62 Million USD | 6946401.765% |
| Psykey, Inc. | -1.29 Million USD | 8714193.371% |
| ConvaTec Group Plc | 455.5 Million USD | -24680.241% |
| ConvaTec Group Plc | 455.5 Million USD | -24680.241% |
| Encision Inc. | -544.19 Thousand USD | 20741562.16% |
| Golden Valley Development, Inc | -141.81 Thousand USD | 79595333.058% |
| Hear AtLast Holdings, Inc. | -109.93 Thousand USD | 102678167.861% |
| Innovative MedTech Inc. | -7.67 Million USD | 1470997.729% |
| LifePoint, Inc. | -14.2 Million USD | 794867.717% |
| Medite Cancer Diagnostics, Inc. | -6.18 Million USD | 1824473.687% |
| Paradigm Medical Industries, Inc. | -325 Thousand USD | 34730561.538% |
| QuantRx Biomedical Corporation | - USD | -Infinity% |
| Remedent, Inc. | -215.23 Thousand USD | 52442557.976% |
| Reflect Scientific, Inc. | -405.78 Thousand USD | 27816376.64% |
| SmileDirectClub, Inc. | -186.13 Million USD | 60739.63% |
| Sector 10, Inc. | - USD | -Infinity% |
| Shandong Weigao Group Medical Polymer Company Limited | 447.82 Million USD | -25104.97% |
| SheerVision, Inc. | -110.53 Thousand USD | 102119867.305% |
| United Health Products, Inc. | -2.5 Million USD | 4511065.089% |
| Vasamed, Inc. | -4.57 Million USD | 2467592.21% |
| Wearable Health Solutions, Inc. | -2.26 Million USD | 4992898.805% |
| Yubo International Biotech Limited | -1.17 Million USD | 9584488.368% |